Cerebrospinal fluid free light chains compared to oligoclonal bands as biomarkers in multiple sclerosis

Cerebrospinal fluid (CSF) free light chains (FLC) may be an alternative biomarker to oligoclonal bands (OCB) in multiple sclerosis (MS). Herein, we compared the diagnostic accuracy of CSF OCB and FLC and we tested the prognostic value of FLC in a cohort of 64 MS patients and 106 controls. A κ-index...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of neuroimmunology 2020-02, Vol.339, p.577108-577108, Article 577108
Hauptverfasser: Gaetani, Lorenzo, Di Carlo, Marinella, Brachelente, Giovanni, Valletta, Federico, Eusebi, Paolo, Mancini, Andrea, Gentili, Lucia, Borrelli, Angela, Calabresi, Paolo, Sarchielli, Paola, Ferri, Carla, Villa, Alfredo, Di Filippo, Massimiliano
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Cerebrospinal fluid (CSF) free light chains (FLC) may be an alternative biomarker to oligoclonal bands (OCB) in multiple sclerosis (MS). Herein, we compared the diagnostic accuracy of CSF OCB and FLC and we tested the prognostic value of FLC in a cohort of 64 MS patients and 106 controls. A κ-index >7.83 was more sensitive but less specific than OCB in discriminating MS patients from controls. Additionally, a κ-index >10.61 performed better than OCB in the discrimination between MS and controls with inflammatory neurological diseases (p 10.61 significantly predicted time to conversion to MS (p = .020). κ-index might be a valid alternative to OCB as a diagnostic biomarker for MS and might also be a prognostic marker in CIS. [Display omitted] •κ-index is more sensitive and less specific than OCB for MS diagnosis.•κ-index performs better than OCB in discriminating MS from other inflammatory neurological diseases.•κ-index correlates with different disease characteristics in MS.•κ-index predicts disease activity in early MS patients.
ISSN:0165-5728
1872-8421
DOI:10.1016/j.jneuroim.2019.577108